Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-25 @ 2:34 AM
NCT ID:
NCT02510534
Eligibility Criteria:
Inclusion Criteria:
* Age 18-37
* BMI 19-34 kg/m2
* Day 2-3 Follicle stimulating hormone (FSH) less than 10IU/mL
* Estradiol (E2) less than 80 pg/mL
* Anti-mullerian hormone (AMH) more than 1.5 ng/mL; or antral follicle count (AFC) up to 10
* Two patent fallopian tubes confirmed by hysterosalpingogram (HSG) or chromopertubation
* Normal uterine cavity confirmed by HSG, saline sonohysterogram (SIS) or hysteroscopy
Exclusion Criteria:
* Severe male factor (total count less than 10 million sperm)
* Systemic diseases not limited to diabetes
* Pregnancy within 3 months
* More than 1 prior cycle of gonadotropin treatment
* Any ovarian cyst \>15mm that has persisted for \> 1 month
* Endometrioma and/or Endometriosis-stage III or IV
* Submucosal uterine fibroids; untreated endometrial polyps \>1 cm;abnormal reproductive tract bleeding
* Intolerance or allergy to study drug
* Substance abuse (including alcohol and tobacco)
* History of chemotherapy (except for gestational conditions) or radiotherapy
* Minors and those adults not capable of consenting on their own
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
37 Years
Study:
NCT02510534
Study Brief:
Protocol Section:
NCT02510534